AUTHOR=Li Zhuo , Lu Gang , Li Zhe , Wu Bin , Luo Enli , Qiu Xinmin , Guo Jianwen , Xia Zhangyong , Zheng Chunye , Su Qiaozhen , Zeng Yan , Chan Wai Yee , Su Xianwei , Cai Qiaodi , Xu Yanjuan , Chen Yingjun , Wang Mingbang , Poon Wai Sang , Luo Xiaodong TITLE=Altered Actinobacteria and Firmicutes Phylum Associated Epitopes in Patients With Parkinson’s Disease JOURNAL=Frontiers in Immunology VOLUME=12 YEAR=2021 URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.632482 DOI=10.3389/fimmu.2021.632482 ISSN=1664-3224 ABSTRACT=
Recent evidence suggests that inflammation was participated in the pathogenesis of PD, thus, to understand the potential mechanism of gut microbiota in the pathogenesis of Parkinson’s disease (PD), we performed a metagenomic analysis of fecal samples from PD patient and controls. Using a two-stage metagenome-wide association strategy, fecal DNA samples from 69 PD patients and 244 controls in three groups (comprising 66 spouses, 97 age-matched, and 81 normal samples, respectively) were analyzed, and differences between candidate gut microbiota and microbiota-associated epitopes (MEs) were compared. In the study, 27 candidate bacterial biomarkers and twenty-eight candidate epitope peptides were significantly different between the PD patients and control groups. Further, enriched 4 and 13 MEs in PD were positively associated with abnormal inflammatory indicators [neutrophil percentage (NEUT.1), monocyte count/percentage (MONO/MONO.1), white blood cell count (WBC)] and five candidate bacterial biomarkers (c_Actinobacteria, f_Bifidobacteriaceae,